VA FSS Schedule 65IB
Schedule 65 I B – Drugs, Pharmaceuticals, & Hematology Related Products
VA IDIQ Active - Obligated to date
- $423.5M
- Task orders
- 579
- Companies awarded
- 127
Vehicle overview
Schedule 65 I B – Drugs, Pharmaceuticals, & Hematology Related Products is a multiple-award IDIQ vehicle managed by the Department of Veterans Affairs (VA) National Acquisition Center. It provides pre-negotiated pricing for pharmaceuticals and hematology-related products to streamline healthcare acquisitions for the federal government. The vehicle is one of the most widely used VA FSS schedules, recording over $18 billion in total sales in fiscal year 2024, including $11.67 billion in VA sales and $6.38 billion in sales to other government agencies.
Covered products include non-prescription medicated cosmetics, generic and over-the-counter drugs, IV delivery systems, nutritional supplements, and soaps and dispensing equipment. Eligible users include VA facilities, federal agencies across the executive, legislative, and judicial branches, the District of Columbia, and certain mixed ownership government corporations.
Vehicle details
- Ordering period
-
5-year base period
VA FSS Schedule 65IB contract holders
| Contractor | Obligated | Task orders |
|---|---|---|
| CHARTWELL RX LLC | $197.7M | 2 |
| PROGENICS PHARMACEUTICALS INC | $95.1M | 124 |
| ADVANCED ACCELERATOR APPLICATIONS USA INC | $71.8M | 118 |
| USANTIBIOTICS LLC | $30.0M | 1 |
| SAGENT PHARMACEUTICALS, INC | $16.6M | 1 |
| OTSUKA AMERICA PHARMACEUTICAL INC | $7.2M | 214 |
| ACORDA THERAPEUTICS, INC. | $938.1K | 2 |
| MERCK SHARP & DOHME LLC | $913.0K | 28 |
| VALNEVA USA, INC. | $719.7K | 1 |
| AUTOLUS INC | $401.0K | 1 |
| JANSSEN PRODUCTS, LP | $317.6K | 14 |
| ELI LILLY AND COMPANY | $281.9K | 2 |
| TRILLAMED LLC | $245.4K | 3 |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | $228.8K | 7 |
| NAPO PHARMACEUTICALS INC | $164.0K | 4 |
Top 15 of 127 companies by obligations.
NAICS coverage
Frequently asked questions
- What is VA FSS Schedule 65IB?
- Schedule 65 I B – Drugs, Pharmaceuticals, & Hematology Related Products is a multiple-award IDIQ vehicle managed by the Department of Veterans Affairs (VA) National Acquisition Center. It provides pre-negotiated pricing for pharmaceuticals and hematology-related products to streamline healthcare acquisitions for the federal government. The vehicle is one of the most widely used VA FSS schedules, recording over $18 billion in total sales in fiscal year 2024, including $11.67 billion in VA sales and $6.38 billion in sales to other government agencies.
- Which agency manages VA FSS Schedule 65IB?
- Schedule 65 I B – Drugs, Pharmaceuticals, & Hematology Related Products is a IDIQ managed by Department of Veterans Affairs.
- What can agencies acquire through VA FSS Schedule 65IB?
- Covered products include non-prescription medicated cosmetics, generic and over-the-counter drugs, IV delivery systems, nutritional supplements, and soaps and dispensing equipment. Eligible users include VA facilities, federal agencies across the executive, legislative, and judicial branches, the District of Columbia, and certain mixed ownership government corporations.
- How much has been obligated through VA FSS Schedule 65IB?
- $423.5M has been obligated across 579 task orders.
- How many contractors hold VA FSS Schedule 65IB?
- 127 contractors hold a position on VA FSS Schedule 65IB.
- Is VA FSS Schedule 65IB active?
- Yes, VA FSS Schedule 65IB is currently active (ordering period: 5-year base period).
Track the contracts behind VA FSS Schedule 65IB
Sweetspot helps capture teams monitor awards, incumbents, recompetes, and agency demand across federal contract vehicles.
Schedule a Demo